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Abstract
Severe Combined Immunodeficiency (SCID) is one of the most severe forms of primary immunodeficiency (PID).
Complications of BCG vaccination, especially disseminated infection and its most severe forms, are known to occur
in immunodeficient patients, particularly in SCID. A carefully taken family history before BCG injection as well as
delaying vaccination if PID is suspected could be a simple and effective method to avoid inappropriate vaccination
of an immunodeficient child in some cases until the prospect of newborn screening for SCID has been fully
developed. We describe a patient with a very early diagnosis of SCID, which was suspected on the basis of the
previous death of two siblings younger than one year due to severe complications secondary to the BCG vaccine.
We suggest that a family history of severe or fatal reactions to BCG should be included as a warning sign for an
early diagnosis of SCID.
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Background
Severe combined immunodeficiency (SCID) represents a
group of heterogeneous diseases that predominantly im-
pair the development of T cells. The main manifestations
are retarded growth and severe recurrent infections
starting in the first year of life, caused by intra- and extra-
cellular microorganisms. Unfortunately, most children are
diagnosed only after the occurrence of severe infections
and their complications, with a considerably worse prog-
nosis. Severe pulmonary and hepatic infections are closely
related to high morbidity and mortality. Thus, SCID is
considered to be a pediatric emergency [1].
In Brazil, the BCG vaccine is given to all children dur-
ing the neonatal period. Dissemination of Mycobacter-
ium bovis (Mb) after BCG vaccination, with a fatal
outcome, may occur in up to 30% of SCID patients [2].
We report a patient with a very early diagnosis of
SCID, which was suspected on the basis of the previous
death of two siblings younger than one year due to
severe complications secondary to the BCG vaccine. We
emphasize the importance of the family history for an
early diagnosis of SCID.
This study was approved by the Ethics Committee of
Clinics Hospital from the University.
Case reports
The first pregnancy resulted in a boy born at term in
good condition. The infant received the BCG vaccine at
seven days of age and progressed without abnormalities
until the third month, when he was hospitalized due to
important weight loss, oral candidiasis and severe pneu-
monia, with no improvement with antibiotic therapy.
Radiological examination demonstrated a bilateral infil-
trate. The infant was transferred to the Intensive Care
Unit due to important clinical worsening and died at five
months of age. Autopsy revealed miliary tuberculosis
(TB) with pulmonary, hepatic and splenic involvement.
Laboratory tests: serial blood counts revealed anemia
and lymphopenia (always below 1000 cells/mm3), and a
blood culture revealed Mb growth.
Similarly, the second pregnancy resulted in a boy born
at term and in good condition. The child received the
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BCG vaccine at seven days of age and developed right
axillary adenomegaly and difficult healing of the vaccin-
ation wound. At two months of age, the child was
treated on an ambulatory basis for acute viral bronchio-
litis and pneumonia, with a poor clinical response. Re-
spiratory discomfort and cough persisted. At four
months of age there was worsening of breathing signs
and symptoms and the onset of fever. Radiological
examination revealed a bilateral infiltrate. The patient
was admitted to the Intensive Care Unit due to respira-
tory insufficiency and died of septic shock. Autopsy re-
vealed miliary TB with pulmonary, mesenteric, renal,
hepatic and splenic involvement. Serial blood counts
showed anemia and lymphopenia (always below 800
cells/mm3) and blood culture revealed Mb growth.
The parents (not consanguineous) were referred to a
tertiary hospital for the investigation of possible untreated
TB that might have caused the death of the children by
vertical transmission. However, the investigation was
negative for TB and immunodeficiency in both parents.
The third pregnancy resulted in a boy born at term in
good condition. Because of the previous history, a blood
count was performed at 12 hours of life, which demon-
strated important lymphopenia (1000 cells/mm3). Con-
sequently, the BCG vaccine was not applied and the
child was referred to the Primary Immunodeficiency
Outpatient Clinic for investigation. At seven days of life,
laboratory tests were performed: a blood count revealed
lymphopenia, quantitation of lymphocyte subtypes by
flow cytometry revealed an important reduction of CD4+
and CD8+ cells (Table 1); a radiography and computed
tomography revealed the absence of the thymus. The
diagnosis of SCID T-B+NK+ was confirmed and trans-
plantation with hematopoietic stem cells was indicated. At
three months the patient showed a reduction of serum im-
munoglobulin levels and replacement therapy was started
with intravenous gamma globulin. An allogeneic trans-
plant of umbilical cord hematopoietic cells was performed
at eight months. The patient coursed with no infections or
graft versus host disease and with good weight-height de-
velopment. The child is now four years old, has no in-
fections and shows appropriate neuropsychomotor and
weight-height development.
Discussion
As we have shown in this article, a family history of se-
vere complications in response to the BCG vaccine can
be an important tool for the early diagnosis of SCID
in infants. Many patients with immunodeficiency are
asymptomatic at birth, so that an early diagnosis permit-
ting the orientation of not using the BCG vaccine is very
difficult. Not all SCID infants have problems with BCG.
Some patients may only have localized infection, but dis-
semination is common and can occur without previous
local signs [3].
Children with SCID are highly susceptible to early
death due to systemic infections caused by attenuated
vaccine strains, such as BCG [2].
The first two children had a similar outcome after
BCG vaccination, progressing with delayed weight gain
and severe respiratory infections. The detection of
multisystemic miliary TB and the identification of Mb in
blood cultures in both infants led to the consistent hy-
pothesis that these severe manifestation were probably
caused by the BCG vaccine. There are eventual reports
of adverse reactions after immunization with BCG in
previously healthy newborns, including atypical evolu-
tion of cicatrization, axillary adenopathy with or without
suppuration, skin abscesses, and severe systemic mani-
festations. However, these conditions require rigorous
clinical monitoring and immunological investigation, a
fact that did not occur with these two infants. This fact
underscores the importance of investigating the im-
munological competence of children younger than one
year with a suspicion of severe infectious manifestations
after receiving attenuated vaccines.
In the present investigation, because of the lack of
confirmation of TB in the parents, the hypothesis of
SCID was raised for the children, considering the early
occurrence and severity of the infectious manifestations
and their time relationship with the BCG vaccines, blood
counts with persistent lymphopenia, and a family history
of early death of a maternal brother due to infection [4].
In addition, the fact that all patients involved were males
suggests an X-linked form of SCID such as the T-B+NK+
phenotype which was identified in our patient. Unfortu-
nately, genetic diagnosis of SCID is still not available in
Table 1 Laboratory exams of the third patient performed
at birth and at seven days of life
Blood count Birth Seven days
Hemoglobin g/mL (14–20)* 16.3 13.9
Hematocrit % (43–63)* 50 43
Platelets/mL (150.000–350.000)* 239.000 393.000
Leukocytes/mL (6400–11000)* 24.400 6.200
Neutrophils/mL (2000–18000) 23180 3410
Lymphocytes/mL (2700–5400)* 1.000 1.600
Eosinophils/mL (200–800)* 244 310
Monocytes/mL (700–1200)* 0 868
Immunophenotyping
CD4+/mL (1700–2800)* - 0
CD8+/mL (800–1200)* - 13
CD19+/mL (500–1500)* - 885
CD16/56+/mL (300–700)* - 702
* Reference values according to age range.
Numbers in bold indicate outside normal ranges.
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Brazil, a fact that prevents us from reaching a more pre-
cise diagnosis. Most children with SCID are lympho-
penic and neonatologists and pediatricians should be
alert to this fact since healthy neonates and infants have
a lymphocyte count exceeding 2500/mL. Thus, persist-
ent lymphopenia below 2500/mL is a warning signal for
SCID in this age group [5].
Referral of the parents to the University Hospital due
to the fatal history of the previous children led to moni-
toring of the current pregnancy at a tertiary care hos-
pital. A simple blood count at birth which detected
profound lymphopenia was sufficient to raise the suspi-
cion of SCID and to refer the patient to investigation.
The diagnosis of SCID was made very early in the third
child, a fact that permitted curative intervention by allo-
geneic hematopoietic cell transplantation with highly
satisfactory results. The prognosis and survival of pa-
tients with SCID are directly related to the age at trans-
plant. When the transplant is performed during the first
three months of life and before the onset of infections,
the survival is approximately 91% [2].
The most frequent clinical manifestation of BCG com-
plication is disseminated infection in patients with SCID
[6], as was observed with our patients. Therefore, the oc-
currence of disseminated TB due to the Mb strain of the
vaccine should alert the pediatrician to the possibility of
primary immunodeficiency (PID), especially SCID [3].
Mortality related to disseminated BCG infection alone
or in association with other causes remains a serious
problem for PID patients. Talbot et al. [7] reported a
mortality rate of more than 70% for immunodeficient
patients despite aggressive anti-TB therapy. Romanus
et al. [8] suggested that vaccination should be postponed
to 6 months of age in countries where there is a low
general risk of neonatal TB. On the other hand, Brazil
belongs to the group of 22 countries in the world that
concentrate 82% of TB cases. The incidence of the dis-
ease in Brazil was 36/100,000 inhabitants in 2011, which
has improved over the last decade but still remains very
high. In this context, the BCG vaccine is still considered
very important, especially against meningeal and miliary
forms of TB, although controversy exists about its pro-
tective efficacy against the clinical form that has the
greatest impact on TB control, namely pulmonary TB.
Perhaps a carefully taken family history before BCG ad-
ministration as well as delaying vaccination if a PID is
suspected could be an effective method to avoid in-
appropriate vaccination of an immunodeficient child in
some cases until the prospect of newborn screening for
SCID has been fully developed.
The median age at diagnosis of SCID is between 4 and
7 months of life [9]. In many situations, the diagnosis in
children without a suggestive family history is made later
as a consequence of the multiple infections or of the
severe reactions to the BCG vaccine [5]. In this respect,
in order to facilitate an early diagnosis of PID in neo-
nates, Griffith et al. [10] proposed the presence of at
least one of these findings: a family history of infant death
or immunodeficiency, delayed weight-height growth dur-
ing the first months of life, infections with opportunistic
pathogens without evidence of HIV infection, severe viral
infections, absence of the thymus in a chest radiogram,
microcephaly, and hospitalization due to septicemia asso-
ciated with lymphopenia.
We conclude that, in those countries where BCG vac-
cine is used, pediatricians must be alert of its severe or
fatal complications in other family members. This
should be included as a warning sign and can be an im-
portant tool for the early diagnosis of SCID or of other
severe forms of PID, contributing to a better prognosis.
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